Benitec Biopharma Ltd ADR (BNTC)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Dr. Jerel A. Banks Ph.D., M.D.
Employees:
3940 Trust Way Hayward, CA 94545
510-780-0819

Benitec Biopharma, Inc., a development-stage biotechnology company, focuses on the advancement of novel genetic medicines.

Data derived from most recent annual or quarterly report
Market Cap 9.969 Million Shares Outstanding8.172 Million Avg 30-day Volume 4.856 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.62
Price to Revenue130.6911 Debt to Equity0.0 EBITDA-17.625 Million
Price to Book Value2.5374 Operating Margin-11623.972600000001 Enterprise Value10.451 Million
Current Ratio4.631 EPS Growth0.457 Quick Ratio4.523
1 Yr BETA 1.425 52-week High/Low 4.78 / 0.74 Profit Margin-11742.4658
Operating Cash Flow Growth-49.732 Altman Z-Score-20.5082 Free Cash Flow to Firm -11.828 Million
View SEC Filings from BNTC instead.

View recent insider trading info

Funds Holding BNTC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BNTC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BUCHI J KEVIN

  • Director
12,000 2021-12-08 1

SMITH EDWARD F

  • Director
12,000 2021-12-08 1

FRANCIS PETER

  • Director
12,000 2021-12-08 1

OLIVEIRA STEVEN MICHAEL

  • 10% Owner
1,000,000 2021-04-28 0

BOSTON MEGAN EXECUTIVE DIRECTOR

  • Officer
  • Director
0 2020-12-09 0

BANKS JEREL A. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-12-09 0

NANT CAPITAL, LLC

SOON-SHIONG PATRICK

CALIFORNIA CAPITAL EQUITY, LLC

  • 10% Owner
293,058 2020-04-15 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BENITEC BIOPHARMA INC BNTC 2022-06-24 14:45:03 UTC -15.7036 17.2736 35000
BENITEC BIOPHARMA INC BNTC 2022-06-24 14:15:03 UTC -15.7036 17.2736 35000
BENITEC BIOPHARMA INC BNTC 2022-06-24 13:45:03 UTC -15.7036 17.2736 35000
BENITEC BIOPHARMA INC BNTC 2022-06-24 13:15:03 UTC -15.7036 17.2736 35000
BENITEC BIOPHARMA INC BNTC 2022-06-24 12:45:03 UTC -15.7036 17.2736 35000
BENITEC BIOPHARMA INC BNTC 2022-06-23 22:15:03 UTC -15.7036 17.2736 50000
BENITEC BIOPHARMA INC BNTC 2022-06-23 21:45:03 UTC -15.7036 17.2736 50000
BENITEC BIOPHARMA INC BNTC 2022-06-23 21:15:04 UTC -15.7036 17.2736 50000
BENITEC BIOPHARMA INC BNTC 2022-06-23 20:45:03 UTC -15.7036 17.2736 50000
BENITEC BIOPHARMA INC BNTC 2022-06-23 20:15:03 UTC -15.7036 17.2736 50000
BENITEC BIOPHARMA INC BNTC 2022-06-23 19:45:03 UTC -15.7036 17.2736 50000
BENITEC BIOPHARMA INC BNTC 2022-06-23 19:15:03 UTC -15.7036 17.2736 50000
BENITEC BIOPHARMA INC BNTC 2022-06-23 18:45:03 UTC -15.7036 17.2736 50000
BENITEC BIOPHARMA INC BNTC 2022-06-23 18:15:04 UTC -15.7036 17.2736 50000
BENITEC BIOPHARMA INC BNTC 2022-06-23 17:45:04 UTC -15.7036 17.2736 50000
BENITEC BIOPHARMA INC BNTC 2022-06-23 17:15:03 UTC -15.7036 17.2736 50000
BENITEC BIOPHARMA INC BNTC 2022-06-23 16:45:03 UTC -15.7036 17.2736 50000
BENITEC BIOPHARMA INC BNTC 2022-06-23 16:15:03 UTC -15.7036 17.2736 50000
BENITEC BIOPHARMA INC BNTC 2022-06-23 15:45:03 UTC -15.7036 17.2736 45000
BENITEC BIOPHARMA INC BNTC 2022-06-23 15:15:03 UTC -15.7036 17.2736 45000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments